Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HAEMONETICS CORP | EVP, Chief Financial Officer | Common Stock | 30.3K | $2.62M | $86.39 | Aug 23, 2021 | Direct |
ViewRay, Inc. | Chief Financial Officer | Common Stock | 356K | $1.57M | $4.40 | Mar 1, 2023 | Direct |
Axogen, Inc. | Director | Common Stock | 28.6K | $219K | $7.68 | Sep 1, 2024 | Direct |
Axogen, Inc. | Director | Employee Stock Option (right to purchase) | 18.2K | $163K | $8.95 | Jun 6, 2024 | Direct |
Axogen, Inc. | Director | Restricted Stock Units | 0 | $0 | $7.68 | Sep 1, 2024 | Direct |
ViewRay, Inc. | Chief Financial Officer | Performance Units | 104K | Mar 1, 2023 | Direct | ||
HAEMONETICS CORP | EVP, Chief Financial Officer | Non-qualified Stock Option (Right to Buy) | 0 | Aug 23, 2021 | Direct | ||
Miromatrix Medical Inc. | Director | Common Stock | 0 | $1.60 | Dec 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXGN | Axogen, Inc. | Sep 1, 2024 | 2 | $0 | 4 | Sep 4, 2024 | Director |
AXGN | Axogen, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
MIRO | Miromatrix Medical Inc. | Dec 12, 2023 | 2 | $0 | 4 | Dec 13, 2023 | Director |
AXGN | Axogen, Inc. | Sep 1, 2023 | 2 | $0 | 4 | Sep 7, 2023 | Director |
AXGN | Axogen, Inc. | Aug 23, 2023 | 2 | $103K | 4 | Aug 25, 2023 | Director |
MIRO | Miromatrix Medical Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director |
MIRO | Miromatrix Medical Inc. | Mar 10, 2023 | 1 | $50K | 4 | Mar 30, 2023 | Director |
VRAYQ | ViewRay, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Chief Financial Officer |
VRAYQ | ViewRay, Inc. | Jan 16, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Chief Financial Officer |
VRAYQ | ViewRay, Inc. | Jan 9, 2023 | 0 | $0 | 3 | Jan 12, 2023 | Chief Financial Officer |
MIRO | Miromatrix Medical Inc. | Aug 10, 2022 | 1 | $0 | 4 | Aug 16, 2022 | Director |
AXGN | Axogen, Inc. | Jul 19, 2022 | 1 | $483K | 4 | Jul 19, 2022 | Director |
AXGN | Axogen, Inc. | Jul 11, 2022 | 0 | $0 | 3 | Jul 19, 2022 | Director |
MIRO | Miromatrix Medical Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Director |
MIRO | Miromatrix Medical Inc. | Jan 3, 2022 | 0 | $0 | 3 | Jan 5, 2022 | Director |
HAE | HAEMONETICS CORP | Aug 23, 2021 | 5 | -$511K | 4 | Aug 25, 2021 | EVP, Chief Financial Officer |
HAE | HAEMONETICS CORP | Jul 1, 2021 | 1 | -$286K | 4 | Jul 6, 2021 | EVP, Chief Financial Officer |
HAE | HAEMONETICS CORP | Jun 14, 2021 | 1 | -$11.4K | 4 | Jun 16, 2021 | EVP, Chief Financial Officer |
HAE | HAEMONETICS CORP | Jun 7, 2021 | 1 | -$22.6K | 4 | Jun 9, 2021 | EVP, Chief Financial Officer |
HAE | HAEMONETICS CORP | May 18, 2021 | 4 | -$13.1K | 4 | May 20, 2021 | EVP, Chief Financial Officer |
HAE | HAEMONETICS CORP | May 17, 2021 | 1 | -$12.3K | 4 | May 18, 2021 | EVP, Chief Financial Officer |